Wiiliam A. Boeger
Oprichter bij Chronix Biomedical, Inc.
Profiel
Wiiliam A.
Boeger is the founder who starts Chronix Biomedical, Inc. in 1997, where he currently serves as Director & Director-Business Development.
He was previously Chairman & Chief Executive Officer at Calypte Biomedical Corp.
and held positions as Faculty at Dartmouth College and Principal at Harvard Medical School.
Boeger holds an MBA from Harvard University and an undergraduate degree from Williams College.
Actieve functies van Wiiliam A. Boeger
| Bedrijven | Functie | Begin |
|---|---|---|
Chronix Biomedical, Inc.
 Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | Oprichter | 01-01-1997 |
Eerdere bekende functies van Wiiliam A. Boeger
| Bedrijven | Functie | Einde |
|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | - |
| Dartmouth College | Corporate Officer/Principal | - |
| CALYPTE BIOMEDICAL CORPORATION | Voorzitter | - |
Opleiding van Wiiliam A. Boeger
| Williams College | Undergraduate Degree |
| Harvard University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Chronix Biomedical, Inc.
Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | Health Technology |
Calypte Biomedical Corp.
 Calypte Biomedical Corp. Medical SpecialtiesHealth Technology Calypte Biomedical Corp. develops, manufactures and distributes vitro testing products, which improves the diagnosis of Human Immunodeficiency Virus infection, sexually transmitted diseases and other chronic diseases. The company's product line includes both point-of-case rapid tests and the BED incidence test. Calypte Biomedical was founded in 1988 and is headquartered in Portland, OR. | Health Technology |
